Capricor Therapeutics Inc (NASDAQ: CAPR) is -29.42% lower on its value in year-to-date trading and has touched a low of $3.52 and a high of $23.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CAPR stock was last observed hovering at around $9.48 in the last trading session, with the day’s gains setting it 0.26%.
Currently trading at $9.74, the stock is -20.91% and -28.92% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing 2.80% at the moment leaves the stock -16.68% off its SMA200. CAPR registered 37.28% gain for a year compared to 6-month loss of -35.96%. The firm has a 50-day simple moving average (SMA 50) of $13.7034 and a 200-day simple moving average (SMA200) of $11.68975.
The stock witnessed a -28.91% gain in the last 1 month and extending the period to 3 months gives it a -29.22%, and is -26.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.69% over the week and 10.38% over the month.
Capricor Therapeutics Inc (CAPR) has around 160 employees, a market worth around $444.88M and $22.27M in sales. Fwd P/E is 154.95. Profit margin for the company is -181.71%. Distance from 52-week low is 176.70% and -58.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-27.08%).
with sales reaching $3.16M over the same period.The EPS is expected to grow by 66.96% this year, but quarterly earnings will post 184.04% year-over-year. Quarterly sales are estimated to shrink -35.63% in year-over-year returns.
149.0 institutions hold shares in Capricor Therapeutics Inc (CAPR), with institutional investors hold 45.85% of the company’s shares. The shares outstanding are 45.58M, and float is at 40.12M with Short Float at 22.61%. Institutions hold 38.16% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 1.63 million shares valued at $7.77 million. The investor’s holdings represent 5.1145 of the CAPR Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.55 million shares valued at $7.39 million to account for 4.9401 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.64 million shares representing 2.0149 and valued at over $3.06 million, while MILLENNIUM MANAGEMENT LLC holds 1.5059 of the shares totaling 0.48 million with a market value of $2.29 million.
Capricor Therapeutics Inc (CAPR) Insider Activity
The most recent transaction is an insider purchase by Nippon Shinyaku Co Ltd, the company’s 10% Owner. SEC filings show that Nippon Shinyaku Co Ltd bought 2,798,507 shares of the company’s common stock on Sep 20 ’24 at a price of $5.36 per share for a total of $15.0 million. Following the purchase, the insider now owns 7.09 million shares.
